When mRNA (messenger RNA) vaccines are injected into a patient, tiny lipid vesicles transport mRNA molecules through the body fluids and merge with immune cells, called antigen-presenting cells (APCs). mRNA vaccines work to instruct APCs to manufacture proteins called antigens that evoke an immune response to the threat.

How mRNA COVID-19 vaccines work to fight COVID-19
Related CAS Insights
Drug Discovery
A review of the global efforts on COVID-19 vaccine development
March 29, 2021
Read articleDrug Discovery
ACE2: Targeting a potentially important receptor in disease pathogenesis
December 15, 2022
Read articleDrug Discovery
ACS webinar on molecular glues and targeted protein degradation
October 12, 2022
Read article